UOC
TVGN icon

UBS O'Connor’s Tevogen Inc. Common Stock TVGN Stock Holding History

UBS O'Connor’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-9,545
Closed -$4.85M – 357
2022
Q3 		$4.85M Sell
9,545
-955
-9% -$482K 0.06% 226
2022
Q2 		$5.25M Buy
+10,500
New +$5.26M 0.05% 226

Other funds holding TVGN

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

UBS O'Connor's TVGN Position: Q4 2022 in Review

UBS O'Connor sold out of Tevogen Inc. Common Stock (TVGN) in Q4 2022, closing a stake of 9,545 shares — an estimated $4.85M sold.

UBS O'Connor first reported a position in TVGN in Q2 2022 and held it in 2 quarters. The position peaked at $5.25M in Q2 2022. 64 funds tracked by Wall St. Rank hold TVGN as of Q4 2022.

  • UBS O'Connor reported no remaining Tevogen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • UBS O'Connor sold 9,545 Tevogen Inc. Common Stock shares in Q4 2022, an estimated $4.85M.
  • UBS O'Connor first reported a position in Tevogen Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • UBS O'Connor's Tevogen Inc. Common Stock position peaked at $5.25M in Q2 2022.
  • 64 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.